DeepMed Research

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

Phase 4

Completed

Conditions: Cataract
Aphakia

Interventions: Device: The Bausch & Lomb Akreos TL IOL (MI60) posterior chamber IOL

First Posted Date: 2009-02-06

Last Posted Date: 2011-12-09

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 125

Registration Number: NCT00838045

Locations: 🇩🇪
Klinikum der J.W. Goethe-Universität, Frankfurt, Germany

Safety and Effectiveness of the Akreos Toric Intraocular Lens.

Phase 4

Completed

Conditions: Cataract
Astigmatism

Interventions: Device: Akreos Toric IOL
Device: Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)

First Posted Date: 2009-01-21

Last Posted Date: 2013-03-25

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 198

Registration Number: NCT00825513

Locations: 🇸🇪
Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital, Umea, Sweden

Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects

Phase 1

Completed

Conditions: Cataract Extraction

Interventions: Drug: Besifloxacin hydrochloride
Drug: moxifloxacin hydrochloride
Drug: gatifloxacin

First Posted Date: 2009-01-16

Last Posted Date: 2011-12-13

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 105

Registration Number: NCT00824070

Locations: 🇺🇸
Ophthalmic Consultants of Long Island, Rockville Center, New York, United States

Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.

Not Applicable

Terminated

Conditions: Cataract

Interventions: Device: Akreos MI Five-O

First Posted Date: 2008-12-09

Last Posted Date: 2014-01-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 10

Registration Number: NCT00804726

Locations: 🇩🇪
Augenzentrum Maus Wolfsstr 16, Koln, Germany

Clinical Evaluation of a New Aspheric Intraocular Lens.

Phase 4

Completed

Conditions: Cataract

Interventions: Device: Akreos Adapt in fellow operated eye.
Device: Advanced Akreos Adapt in one operated eye.

First Posted Date: 2008-11-06

Last Posted Date: 2011-12-12

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 75

Registration Number: NCT00786565

A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Johnson and Johnson 1-Day Acuvue Moist contact lenses
Device: Novel Bausch & Lomb daily disposable contact lenses
Device: Bausch & Lomb SofLens daily disposable contact lenses.

First Posted Date: 2008-11-04

Last Posted Date: 2020-10-06

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 567

Registration Number: NCT00784641

Locations: 🇺🇸
Dr. James Ferrari, Rochester, New York, United States

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

Phase 3

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Ketotifen/naphazoline
Drug: Vehicle
Drug: Naphazoline
Drug: Ketotifen

First Posted Date: 2008-10-09

Last Posted Date: 2020-10-27

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 141

Registration Number: NCT00770133

Locations: 🇺🇸
Ophthalmic Research Consultants, Inc., North Andover, Massachusetts, United States

Technolas 217z Laser With Zyoptix Aspheric Algorithm Used for the LASIK Treatment of Myopia and Myopic Astigmatism.

Not Applicable

Completed

Conditions: Astigmatism
Myopia

Interventions: Device: Bausch & Lomb 217z Excimer Laser

First Posted Date: 2008-10-09

Last Posted Date: 2020-09-11

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 72

Registration Number: NCT00769808

Locations: 🇨🇦
Lasik MD, 130 King Street, Toronto, Ontario, Canada

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

Phase 3

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Vehicle
Drug: Ketotifen/naphazoline
Drug: Ketotifen
Drug: Naphazoline

First Posted Date: 2008-10-09

Last Posted Date: 2024-04-03

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 144

Registration Number: NCT00769886

Locations: 🇺🇸
Ophthalmic Research Consultants, Inc., North Andover, Massachusetts, United States

Comparative Study of the Wearing Satisfaction of Two Soft Contact Lens Designs.

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: PureVision 1
Device: PureVision 2

First Posted Date: 2008-10-08

Last Posted Date: 2013-03-18

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 64

Registration Number: NCT00768885

Locations: 🇯🇵
Kodama Eye Clinic, Kyoto, Japan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy